CeleCor Therapeutics, Inc. — Form D/A
CeleCor Therapeutics, Inc. of DEL MAR, CA, a company, filed a Form D amendment with the SEC on 2023-08-03. The offering totals $42.5M, of which $17.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-03
- Form: D/A
- Accession: 0001705381-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.5M
- Amount sold: $17.8M
- Remaining: $24.8M
- Investors: 11
- Date of first sale: 2022-02-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-436346
Issuer
- Name: CeleCor Therapeutics, Inc.
- CIK: 0001705381
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1155 CAMINO DEL MAR SUITE 481, DEL MAR, CA, 92014
- Phone: 858-777-9750
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jack B Lief | Director | Del Mar, CA |
| Andreas B Ritzi | Director | Zug, V8 |
| Robert Hillman | Director | Del Mar, CA |
| Robert Hillman | Executive Officer | Del Mar, CA |
| Andreas S Ritzi | Director | San Diego, CA |
| Caspar FV Sturm | Director | San Diego, CA |
| Robert S Hillman | Director | San Diego, CA |
| Robert S Hillman | Executive Officer | San Diego, CA |
| Peter B Finn | Executive Officer | Boston, MA |
| JACK LIEF | Related Person | Del Mar, CA |
| Robert S. Hillman, Ph.D. | Related Person | Del Mar, CA |
| Andreas Ritzi | Related Person | Del Mar, CA |
| Peter B. Finn | Related Person | Boston, MA |
Other filings by this issuer (5)
More